Owens & Minor Q3 Loss Widens, But Revenue Rises; Backs Annual Outlook

Owens & Minor, Inc. (OMI) reported a wider third-quarter net loss of $150.27 million, or $1.94 per share, primarily due to discontinued operations, compared to a $12.77 million loss last year. However, the healthcare solutions company's adjusted earnings of $0.25 per share exceeded analyst expectations of $0.24, while revenue increased to $697.24 million. Despite the adjusted earnings beat and reaffirmed full-year 2025 adjusted EPS and revenue guidance, OMI shares declined 12.65% following the announcement.

Analysis

Owens & Minor (OMI) reported a significantly wider third-quarter net loss of $150.27 million, or $1.94 per share, primarily attributed to discontinued operations, compared to a $12.77 million loss in the prior year. Despite this, the company's adjusted earnings per share of $0.25 surpassed analyst expectations of $0.24, though it represents a decrease from $0.36 per share year-over-year. Revenue for the quarter showed modest growth, increasing to $697.24 million from $686.84 million.

The market reacted negatively to the announcement, with OMI shares declining 12.65% to $4.39 on the New York Stock Exchange. This sharp decline suggests investors are more focused on the substantial GAAP loss and the year-over-year decline in adjusted earnings, rather than the slight beat on adjusted EPS relative to consensus. The impact of discontinued operations appears to be a significant concern.

Management reiterated its full-year 2025 adjusted EPS guidance of $1.02 to $1.07 and revenue guidance of $2.76 billion to $2.82 billion. This reaffirmed outlook, despite the Q3 performance and market reaction, indicates management's confidence in future operational stability. However, the immediate share price movement reflects investor skepticism regarding the underlying profitability trends.

Key Decisions for Investors

• Investors should closely monitor the ongoing impact of discontinued operations on OMI's reported net income and cash flow, as this was a primary driver of the wider Q3 loss.
• Evaluate the sustainability of the reaffirmed full-year 2025 guidance against the backdrop of declining adjusted EPS year-over-year and current market sentiment.
• Consider the stock's valuation following the 12.65% decline, assessing whether the market has overreacted to the GAAP loss or if fundamental concerns persist.